Skip to search formSkip to main contentSkip to account menu

Gelucire 50-02

Known as: G 50-02 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Methotrexate (MTX), a potent anticancer drug, shows low oral bioavailability due to its low aqueous solubility and permeability… 
2018
2018
New blends of hydroxypropylmethylcellulose (HPMC, 4000 cps) and Gelucire®44/14 (GE) were utilized to modulate the solubility and… 
2016
2016
The selection of a vehicle for oral formulations of compounds to be used in non‐clinical safety studies is a challenge for poorly… 
2014
2014
SUMMARY Telmisartan (TEL) melt dispersions and tablets were formulated using alkalisers and low melting excipients. Tablets were… 
2013
2013
Non steroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed medications to the geriatric patients for the treatment of… 
2010
2010
The purpose of our study was the formulation and preparation of orally disintegrating tablets (ODT) containing an analgesic… 
2005
2005
PURPOSE The objective of this work was to prepare theophylline sustained release matrix tablets based on the combination of… 
2004
2004
Recently, self-emulsifying drug delivery systems (SEDDS) have been developed as a method to deliver lipophilic drugs. Gelucire… 
1999
1999
Theophylline extended-release spheres were prepared by extrusion-spheronization of matrix granulations previously obtained by…